President Donald Trump’s move to fire two Democrats on the Federal Trade Commission leaves a question mark over the future of an agency antitrust action alleging pharmacy benefit managers used illegal rebate programs that spiked the price of insulin.
The FTC last September sued units of
Commissioners have ultimate authority over decisions in the FTC’s in-house court. But at the time of their dismissal on March 18, Alvaro Bedoya and Rebecca ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.